J Korean Med Sci.
2018 Aug;33(34):e228. 10.3346/jkms.2018.33.e228.
Importance and What to Watch Out for de novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
- Affiliations
-
- 1Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. yangch@catholic.ac.kr
- KMID: 2418617
- DOI: http://doi.org/10.3346/jkms.2018.33.e228
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Characteristics and Clinical Significance of de novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
- Continuous Monitoring of Donor Specific Anti-HLA Antibody in Kidney Transplantation Patients
- Association of human leukocyte antigen homozygosity and de novo malignancies in kidney transplant recipients
- Evaluating the effect of Anti-HLA-DR51/52/53 donor-specific antibodies on antibody-mediated rejection in kidney transplantation recipients
- Effect of preexisting human leukocyte antigen donor-specific antibodies especially human leukocyte antigen-DQ on kidney transplant outcome
